rs1515495
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003722.5(TP63):c.325-12014A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.103 in 152,052 control chromosomes in the GnomAD database, including 1,048 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.10   (  1048   hom.,  cov: 32) 
Consequence
 TP63
NM_003722.5 intron
NM_003722.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.722  
Publications
5 publications found 
Genes affected
 TP63  (HGNC:15979):  (tumor protein p63) This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016] 
TP63 Gene-Disease associations (from GenCC):
- ADULT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- ankyloblepharon-ectodermal defects-cleft lip/palate syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- limb-mammary syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- Rapp-Hodgkin syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- premature ovarian failure 21Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- split hand-foot malformation 4Inheritance: AD Classification: MODERATE Submitted by: Illumina
- EEC syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- split hand-foot malformationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.167  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TP63 | NM_003722.5 | c.325-12014A>G | intron_variant | Intron 3 of 13 | ENST00000264731.8 | NP_003713.3 | ||
| TP63 | NM_001114980.2 | c.42+6416A>G | intron_variant | Intron 1 of 11 | ENST00000354600.10 | NP_001108452.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TP63 | ENST00000264731.8 | c.325-12014A>G | intron_variant | Intron 3 of 13 | 1 | NM_003722.5 | ENSP00000264731.3 | |||
| TP63 | ENST00000354600.10 | c.42+6416A>G | intron_variant | Intron 1 of 11 | 1 | NM_001114980.2 | ENSP00000346614.5 | 
Frequencies
GnomAD3 genomes  0.102  AC: 15557AN: 151934Hom.:  1037  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
15557
AN: 
151934
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.103  AC: 15604AN: 152052Hom.:  1048  Cov.: 32 AF XY:  0.103  AC XY: 7646AN XY: 74326 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
15604
AN: 
152052
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
7646
AN XY: 
74326
show subpopulations 
African (AFR) 
 AF: 
AC: 
7048
AN: 
41488
American (AMR) 
 AF: 
AC: 
2402
AN: 
15246
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
159
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
665
AN: 
5142
South Asian (SAS) 
 AF: 
AC: 
309
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
502
AN: 
10614
Middle Eastern (MID) 
 AF: 
AC: 
17
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
4242
AN: 
67952
Other (OTH) 
 AF: 
AC: 
221
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 691 
 1381 
 2072 
 2762 
 3453 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 168 
 336 
 504 
 672 
 840 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
440
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.